세계의 난관암 치료제 시장(2025-2029년)

The fallopian tube cancer therapeutics market is forecasted to grow by USD 1,196 mn during 2024-2029, accelerating at a CAGR of 10.7% during the forecast period. The report on the fallopian tube cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing attention toward women health, array of strong drug approvals, and rising awareness of gynecological cancers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's fallopian tube cancer therapeutics market is segmented as below:

By End-user

• Hospitals
• Clinics and ASCs
• Others

By Product

• Targeted therapy
• Chemotherapy

By Drug Class

• Biologics
• Small-molecule drugs
• Vaccines
• Combination regimens
• Hormonal agents

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing research on regenerative therapies as one of the prime reasons driving the fallopian tube cancer therapeutics market growth during the next few years. Also, advent of treatment vaccines for cancer and growing usage of nanotechnology for effective treatment will lead to sizable demand in the market.

The report on the fallopian tube cancer therapeutics market covers the following areas:

• Fallopian Tube Cancer Therapeutics Market sizing
• Fallopian Tube Cancer Therapeutics Market forecast
• Fallopian Tube Cancer Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fallopian tube cancer therapeutics market vendors that include AbbVie Inc., Amgen Inc., APIM Therapeutics AS, Arrien Pharmaceuticals LLC, AstraZeneca Plc, Baxter International Inc., BioVaxys Technology Corp., Boehringer Ingelheim International GmbH, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Genmab AS, GlaxoSmithKline Plc, Novartis AG, Pfizer Inc., Shattuck Labs Inc., Siemens Healthineers AG, and Sun Pharmaceutical Industries Ltd.. Also, the fallopian tube cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Fallopian Tube Cancer Therapeutics Market 2019 - 2023
  • Historic Market Size - Data Table on Global Fallopian Tube Cancer Therapeutics Market 2019 - 2023 ($ million)
• 5.2 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.3 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.4 Drug Class segment analysis 2019 - 2023
  • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Fallopian Tube Cancer Therapeutics Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

• 8.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 8.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 8.3 Hospitals - Market size and forecast 2024-2029
  • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
• 8.4 Clinics and ASCs - Market size and forecast 2024-2029
  • Chart on Clinics and ASCs - Market size and forecast 2024-2029 ($ million)
  • Data Table on Clinics and ASCs - Market size and forecast 2024-2029 ($ million)
  • Chart on Clinics and ASCs - Year-over-year growth 2024-2029 (%)
  • Data Table on Clinics and ASCs - Year-over-year growth 2024-2029 (%)
• 8.5 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
  • Chart on Product - Market share 2024-2029 (%)
  • Data Table on Product - Market share 2024-2029 (%)
• 9.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 9.3 Targeted therapy - Market size and forecast 2024-2029
  • Chart on Targeted therapy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Targeted therapy - Market size and forecast 2024-2029 ($ million)
  • Chart on Targeted therapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Targeted therapy - Year-over-year growth 2024-2029 (%)
• 9.4 Chemotherapy - Market size and forecast 2024-2029
  • Chart on Chemotherapy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ million)
  • Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
• 9.5 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

10 Market Segmentation by Drug Class

• 10.1 Market segments
  • Chart on Drug Class - Market share 2024-2029 (%)
  • Data Table on Drug Class - Market share 2024-2029 (%)
• 10.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 10.3 Biologics - Market size and forecast 2024-2029
  • Chart on Biologics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Biologics - Market size and forecast 2024-2029 ($ million)
  • Chart on Biologics - Year-over-year growth 2024-2029 (%)
  • Data Table on Biologics - Year-over-year growth 2024-2029 (%)
• 10.4 Small-molecule drugs - Market size and forecast 2024-2029
  • Chart on Small-molecule drugs - Market size and forecast 2024-2029 ($ million)
  • Data Table on Small-molecule drugs - Market size and forecast 2024-2029 ($ million)
  • Chart on Small-molecule drugs - Year-over-year growth 2024-2029 (%)
  • Data Table on Small-molecule drugs - Year-over-year growth 2024-2029 (%)
• 10.5 Vaccines - Market size and forecast 2024-2029
  • Chart on Vaccines - Market size and forecast 2024-2029 ($ million)
  • Data Table on Vaccines - Market size and forecast 2024-2029 ($ million)
  • Chart on Vaccines - Year-over-year growth 2024-2029 (%)
  • Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
• 10.6 Combination regimens - Market size and forecast 2024-2029
  • Chart on Combination regimens - Market size and forecast 2024-2029 ($ million)
  • Data Table on Combination regimens - Market size and forecast 2024-2029 ($ million)
  • Chart on Combination regimens - Year-over-year growth 2024-2029 (%)
  • Data Table on Combination regimens - Year-over-year growth 2024-2029 (%)
• 10.7 Hormonal agents - Market size and forecast 2024-2029
  • Chart on Hormonal agents - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hormonal agents - Market size and forecast 2024-2029 ($ million)
  • Chart on Hormonal agents - Year-over-year growth 2024-2029 (%)
  • Data Table on Hormonal agents - Year-over-year growth 2024-2029 (%)
• 10.8 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.9 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.10 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.12 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.13 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.14 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.15 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.16 Spain - Market size and forecast 2024-2029
  • Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Data Table on Spain - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 15.5 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
• 15.6 APIM Therapeutics AS
  • APIM Therapeutics AS - Overview
  • APIM Therapeutics AS - Product / Service
  • APIM Therapeutics AS - Key offerings
  • SWOT
• 15.7 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 15.8 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.9 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 15.10 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
• 15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.12 Genmab AS
  • Genmab AS - Overview
  • Genmab AS - Product / Service
  • Genmab AS - Key offerings
  • SWOT
• 15.13 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
  • SWOT
• 15.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 15.16 Shattuck Labs Inc.
  • Shattuck Labs Inc. - Overview
  • Shattuck Labs Inc. - Product / Service
  • Shattuck Labs Inc. - Key offerings
  • SWOT
• 15.17 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key news
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.18 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations